Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
oral contraceptive
|
| gptkbp:activeIngredient |
gptkb:estradiol_valerate
dienogest |
| gptkbp:alternativeName |
Natazia
estradiol valerate/dienogest |
| gptkbp:approvedBy |
gptkb:Therapeutic_Goods_Administration
gptkb:European_Medicines_Agency |
| gptkbp:ATCCode |
G03AA14
|
| gptkbp:contraindication |
gptkb:liver_disease
history of thromboembolic disorders known or suspected pregnancy hormone-sensitive cancer |
| gptkbp:hasDosingRegimen |
28-day cycle
|
| gptkbp:hasPharmaceuticalForm |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Qlaira
|
| gptkbp:manufacturer |
gptkb:Bayer
|
| gptkbp:marketedIn |
gptkb:Australia
gptkb:Europe other countries |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
headache irregular bleeding breast pain |
| gptkbp:usedFor |
birth control
|
| gptkbp:bfsParent |
gptkb:ethinyl_estradiol
|
| gptkbp:bfsLayer |
7
|